During the past decade, Premier Psychiatric Research Institute, LLC conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 13 clinical trials were completed, i.e. on average, 108.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 7 clinical trials were completed. i.e. 350% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Premier Psychiatric Research Institute, LLC" #1 sponsor was "Shire" with 7 trials, followed by "Pfizer" with 4 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Naurex, Inc, an affiliate of Allergan plc" with 2 trials sponsored and "Sunovion" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Premier Psychiatric Research Institute, LLC" #1 collaborator was "Medpace, Inc." with 1 trials as a collaborator and "University of Michigan" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Premier Psychiatric Research Institute, LLC" are "Major Depressive Disorder" (5 trials), "Depressive Disorder, Major" (4 trials), "Adult Attention Deficit Hyperactivity Disorder" (2 trials), "Attention Deficit Hyperactivity Disorder (ADHD)" (2 trials) and "Attention-Deficit/Hyperactivity Disorder" (2 trials). Many other conditions were trialed in "Premier Psychiatric Research Institute, LLC" in a lesser frequency.

Most popular intervention types in "Premier Psychiatric Research Institute, LLC" are "Drug" (19 trials), "Genetic" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "SPD489 (Lisdexamfetamine dimesylate)" (3 trials), "Rapastinel" (2 trials), "SPD489" (2 trials) and "Antidepressant + Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Premier Psychiatric Research Institute, LLC" are 22 trials for "All" genders.

Currently, there are NaN active trials in "Premier Psychiatric Research Institute, LLC". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Premier Psychiatric Research Institute, LLC, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Premier Psychiatric Research Institute, LLC, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 2 trials that are defined as “Not Applicable".